Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation

BACKGROUND: Rivaroxaban is an oral anticoagulant approved in the US for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF). We determined the effectiveness and associated risks of rivaroxaban versus other oral anticoagulants in a large real-world popu...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:BMC Cardiovasc Disord
Main Authors: Norby, Faye L., Bengtson, Lindsay G.S., Lutsey, Pamela L., Chen, Lin Y., MacLehose, Richard F., Chamberlain, Alanna M., Rapson, Ian, Alonso, Alvaro
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2017
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5585896/
https://ncbi.nlm.nih.gov/pubmed/28874129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12872-017-0672-5
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker